PROGRAMME

SUNDAY  10 September
Aula Magna  Chemistry Department G. Ciamician

11:30-14:00

REGISTRATION

14:00-14:30

Dario Braga
Department of Chemistry G. Ciamician, University of Bologna, Italy

Opening of the convention

14:30-15:00

Aurora J Cruz-Cabeza
Department of Chemistry, Durham University, Durham, UK

Crystal size and shape effects in polymorphism

15:00-15:30

Ashwini K. Nangia
Senior Professor of Chemistry, University of Hyderabad, INDIA

Improving solubility and permeability of drugs by cocrystallization

15:30-16:00

Edyta Pindelska
Department of Pharmaceutical Chemistry and Biomaterials, Medical University of Warsaw, Warsaw, Poland

To taste and not to forget. Can crystal engineering solve a problem of Alzheimer’s disease?

16:00-16:30

Lucia Maini
Department of Chemistry G. Ciamician, University of Bologna, Italy

Failure and success in the crystal engineering lab

16:30-17:00

COFFEE BREAK

17:00-17:30

Amy Woods-Ryan
Investigator Materials Science, Drug Substance Development – GSK Medicines Research Centre, Stevenage, Hertfordshire, UK

A to Z of Polymorphs Related by Proton Transfer

17:30-18:00

Helen Wheatcroft
APS Crystallisation Scientist, AstraZeneca, Macclesfield, UK

Crystallisation and Particle Control of a Multi-component API Crystal Form: From Structure to Process

18:00-18:30

Tomislav Friscic
Professor & Leverhulme International Chair in Green and Sustainable Chemistry School of Chemistry – University of Birmingham

Speed-Mixing and Resonant Acoustic Mixing: New Opportunities for Discovery and Scale-up of Polymorphs and Cocrystals

18:30-19:00

Gerard Coquerel
Laboratoire Sciences et Méthodes Separatives. University of Rouen, France.

Access to highly metastable polymorphs after smooth desolvations.
Conditions to fulfil and examples.

19:00

DINNER IN THE COURTYARD

MONDAY 11 September
Hotel Aemilia

8:30-9:00

Jon Steed
Department of Chemistry, Durham University, Durham, UK

Supramolecular Gels – morphology/property relationship and polymorph discovery.

9:00-9:30

Helen Blade
Structural Science, AstraZeneca, Oral Product Development, Pharmaceutical Technology & Development, Operations, Macclesfield, UK

From Crystal Structures to Patients – How AZ uses crystal structure models to risk assess our molecules

9:30-10:00

Robert Geertman
Crystallization Technology Unit Janssen R&D BE API Development, Beerse, Belgium

Navigating a solvate jungle

10:00-10:30

Ana Kwokal
Team Lead, Particle Science at Syngenta, UK

Solid-solution challenges

10:30-11:00

COFFEE BREAK

11:00-11:30

Doris Braun
University of Innsbruck Institute of Pharmacy, Innsbruck, Austria

Experimental and theoretical studies of flavone cocrystals

11:30-12:00

Andrea Anelli
Digitalisation and Data Scientist, Roche Pharma Research and Early Development Roche Innovation Center Basel, Switzerland

Accelerating crystal structure prediction using machine learning

12:00-12:30

Sarah (Sally) Price
Department of Chemistry, University College London, UK

Are we making progress towards polymorph prediction?

12:30-13:00

Marcus A. Neumann
CEO Avant-garde Materials Simulation Deutschland GmbH, Merzhausen, Germany

Crystal Structure Prediction for Ocean Planets 2.0

13:00-14:00

LUNCH

14:00-14:15

Maria Orlova
Malvern Panalytical
Solid form analysis on laboratory X-ray powder diffractometer

14:15-14:30

Andrew Jones
Anton Paar Italia S.r.l.

New opportunities in solid form analysis by powder X-ray diffraction

14:30-14:45

Christian Lübbert
Amofor
Predicting the crystallization onset time in amorphous solid dispersions

14:45-15:00

Volatiana Razafindramanana
SMS/Nordtest
Vapor Sorption Techniques for Crystal Engineering

15:00-15:15

Monica Michieli
Mettler-Toledo S.p.A.
Advantages in using image-based PAT for crystallisation process development

15:15-16:00

COFFEE BREAK

16:00-16:30

Enrico Modena

PolyCrystalLine – Medicina, Bologna, Italy

Polymorphism of APIs and crystallization control

16:30-17:00

Javier Alcides Ellena
São Carlos Institute of Physics – University of São Paulo, Brasil

Antihypertensives Drug-Drug co-crystals: drug combination for the treatment of covid sequels

17:00-17:30

Paroma Chakravarty
Sr. Principal Scientist, Small Molecule Pharmaceutical Sciences Genentech, Inc. South San Francisco, USA

The Importance of Solid-state Chemistry in Advancing the Small Molecule Drug Development Pipeline

17:30-18:45

Discussants Ghazala Sadiq
The Cambridge Crystallographic Data Centre, Cambridge, UK

Susan Reutzel Edens

The Glass Ceiling – Open discussion *

18:45-21:00

Poster session (b) and aperitif

TUESDAY 12 September
Hotel Aemilia

9:00-9:30

Mike Zaworotko
Bernal Chair of Crystal Engineering, Department of Chemical Sciences, AD2-021 University of Limerick Limerick, Ireland

Cocrystals: Then, Now and Next

9:30-10:00

Matteo Daldosso
Material Science Scientific Leader, Aptuit, an Evotec Company, Verona, Italy

The influence of particle attributes on inhalation drug products performance: few non-trivial cases

10:00-10:30

Lidia Tajber
School of Pharmacy and Pharmaceutical Sciences Trinity College Dublin, Dublin, Ireland

To crystallize or not to crystallize – that is the question, but what is better for making good medicines?”

10:30-11:00

COFFEE BREAK

11:00-11:30

Elena Simone
Department of Applied Science and Technology (DISAT) Politecnico di Torino, Torino, Italy

Relating crystal structure to particle surface properties: bringing crystal engineering with particle technology

11:30-12:00

Nicola Sardone
Analytical Research Director INDENA, Settala (Mi), Italy

Dealing with Solid Forms of natural derived APIs in the last quarter of a century

12:00-12:30

Pat Basford
Senior Principal Scientist, Pfizer

The enigma of hydrate kinetic stability, yet a necessity for drug product development

12:30-13:00

Gianluca Bianchini
Medicinal Chemistry Associate Director – Dompé farmaceutici S.p.A, L’Aquila, Italy

Ketoprofen, lysine and gabapentine co-crystal magnifies synergistic efficacy and tolerability of the constituent drugs: pre-clinical evidences towards innovative therapeutic approach for neouroinflammatory pain

13:00-14:00

LUNCH

14:00-14:30

Oleksii Shemchuk
Université Catholique de Louvain – UCLouvain, Louvain-la-Neuve, Belgium

Innovative pathways to chiral resolution using cocrystallization tools

14:30-15:00

Susan Reutzel-Edens
SuRE Pharma Consulting, LLC

Olanzapine, a gift to crystal chemistry that keeps on giving

15:00-15:30

Dejan-Kresimir (Kreso) Bucar
Department of Chemistry, University College London, London, UK

Crystal engineering of palatable medicines: what works and what doesn’t

15:30-16:00

C. Malla Reddy
Department of Chemical Sciences, IISER Kolkata, India

Nanomechanics of Crystal Forms

16:00-16:30

COFFEE BREAK

16:30-17:00

Matteo Guidetti
Solvias AG Römerpark 2 CH-4303 Kaiseraugst, Switzerland

Combining high-throughput experiments and computational tools in the cocrystal screening of posaconazole

17:00-17:30

Alfred Lee, Ph.
Merck Research Laboratories Rahway, New Jersey 07065, USA

Solid Form Science in Chemical Process Development: The Good, The Bad and The Ugly 

17:30-18:30

Dario Braga and Susan Reutzel Edens (discussants)

What next in crystal forms? Open discussion

18:30-19:00

CLOSING REMARKS AND POSTER PRIZES

(a)open discussion led by Ghazala Sadiq and Susan Reutzel Edens (discussants) to address “under the iceberg’ moments” people have experienced, the challenges people face, mentorship and the small changes that may make a difference. 

(b) “best poster” prices are offered by CrystEngComm and by Crystal Growth and Design.

-> The issue of “sustainability of conferences and meetings” will also be addressed via a questionnaire and a poster discussion.

GOLD Sponsor

SILVER Sponsor